3D Cell Culture Global Market - Forecast to 2024 - Product Image

3D Cell Culture Global Market - Forecast to 2024

  • ID: 4464392
  • Report
  • Region: Global
  • 321 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
The 3D Cell Culture Global Market is Expected to Grow at Double Digit CAGR to Reach $1,485.1 Million by 2024

FEATURED COMPANIES

  • 3D Matrix Co (Japan)
  • Ascendance (U.S.)
  • Biolamina AB (Sweden)
  • Corning (U.S.)
  • Fujifilm (Japan)
  • Insphero (Switzerland)
  • MORE

3D cell culture is the method of creating an artificial environment that allows the cells to grow and interact within 3D structures. According to this research, the 3D cell culture global market is expected to grow at double digit CAGR to reach $1,485.1 million by 2024.

Substantial R&D investments, use of 3D cell culture models in drug discovery and research as alternative to animal testing, emergence of microfluidic technology and bioprinting and increasing focus on regenerative medicine are some of the driving factors for this industry. However, lack of experienced and skilled professionals, budget restrictions for small and medium sized laboratories, lack of consistency in 3D cell culture products, stringent process controls for handling capabilities and ethical concerns over the use of animal sources are hindering the market to grow.

3D cell culture global market is classified based on technology, products, application, end-users, and geography. Based on technology the 3D cell culture market can be divided into two segments i.e., Scaffold based approaches and Scaffold free approaches. The scaffold based approaches are further classified into scaffolds, hydrogels and others. The scaffold free approaches are classified as the hang drop method, forced floating, agitation based methods, and microfludics.

Based on products the segment is further classified as cells and tissues, media, sera and reagents, microplates and others, assay kits, scaffolds, and others (bioreactors and incubators). The application segment can be classified as basic research, toxicity and drug screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The end-users segment can be classified as academic institutes, biotechnology and pharmaceutical industries and others.

Based on geography 3D cell culture global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share of 46.2% followed by Europe. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for 3D cell culture products.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3D Matrix Co (Japan)
  • Ascendance (U.S.)
  • Biolamina AB (Sweden)
  • Corning (U.S.)
  • Fujifilm (Japan)
  • Insphero (Switzerland)
  • MORE

1. Executive Summary   

2. Introduction   
2.1 Key Takeaways   
2.2 Report Description   
2.3 Markets Covered   
2.4 Stakeholders   
2.5 Research Methodology   
2.5.1 Market Size Estimation   
2.5.2 Market Breakdown And Data Triangulation   
2.5.3 Secondary Sources   
2.5.4 Primary Sources   
2.5.5 Key Data Points From Secondary Sources   
2.5.6 Key Data Points From Primary Sources   
2.5.7 Assumptions   

3. Market Analysis   
3.1 Introduction   
3.2 Market Segmentation   
3.3 Factors Influencing Market   
3.3.1 Drivers And Opportunities   
3.3.1.1 Substantial R&D Investments For 3D Cell Culture   
3.3.1.2 Use Of 3D Cell Culture Models In Drug Discovery And Research As An
Alternative To Animal Testing   
3.3.1.3 Emergence Of Microfluidic Technology And Bioprinting   
3.3.1.4 Increasing Focus On Regenerative Medicine   
3.3.2 Restraints And Threats   
3.3.2.1 Lack Of Experienced And Skilled Professionals   
3.3.2.2 Budget Restriction For Small And Medium Sized Laboratories And Lack Of
Consistency In 3D Cell Culture Products   
3.3.2.3 Stringent Process Controls For Advanced Handling Capabilities   
3.3.2.4 Ethical Concern Over Use Of Animal Sources   
3.4 Regulatory Affairs   
3.4.1 United States   
3.4.2 Europe   
3.4.3 India   
3.4.4 Japan   
3.5 Technological Advancements   
3.5.1 Introduction   
3.5.2 Organ-On-Chip   
3.5.3 3D Bioprinting   
3.5.4 Single Use Reactors   
3.6 Porter’S Five Force Analysis   
3.6.1 Threat Of New Entrants   
3.6.2 Threat Of Substitutes   
3.6.3 Bargaining Power Of Suppliers   
3.6.4 Bargaining Power Of Buyers   
3.6.5 Rivalry Among Existing Competitors   
3.7 Supply Chain Analysis   
3.7.1 Raw Material Supplier:   
3.7.2 Product Manufacturers:-   
3.7.3 3D Cell Culture Products Distributors   
3.7.4 End-Users   
3.8 Market Share Analysis By Major Players   

4. 3D Cell Culture Global Market, By Technology   
4.1 Introduction   
4.2 Scaffold Based Platforms   
4.2.1 Scaffolds   
4.2.2 Hydrogels   
4.2.3 Others   
4.3 Scaffold Free Platforms   
4.3.1 Hang Drop Method   
4.3.2 Forced Floating   
4.3.3 Agitation Based Methods   
4.3.4 Microfluidics   

5. 3D Cell Culture Global Market, By Products   
5.1 Introduction   
5.2 Cells And Tissues   
5.3 Media, Sera And Reagents   
5.4 Microplates And Others   
5.5 Assay Kits   
5.6 Scaffolds   
5.6.1 Natural Scaffolds   
5.6.2 Synthetic Scaffolds   
5.6.3 Hybrid Composite   
5.6.4 Hydrogels   
5.7 Others   

6. 3D Cell Culture Global Market, By Application   
6.1 Introduction   
6.2 Basic Research   
6.3 Toxicity And Drug Safety Screening   
6.4 Tissue Engineering   
6.5 Stem Cell Research   
6.6 Drug Discovery   
6.7 Cancer Research   
6.8 Gene Therapy   

7. 3D Cell Culture Global Market, By End-Users   
7.1 Introduction   
7.2 Academic Institutes   
7.3 Biotechnology And Pharmaceutical Industries   
7.4 Others   

8. Regional Analysis   
8.1 Introduction   
8.2 North America   
8.2.1 U.S.   
8.2.2 Others   
8.3 Europe   
8.3.1 Germany   
8.3.2 U.K.   
8.3.3 France   
8.3.4 Others   
8.4 Asia-Pacific   
8.4.1 China   
8.4.2 Japan   
8.4.3 Korea   
8.4.4 Others   
8.5 Rest Of The World   
8.5.1 Brazil   
8.5.2 Rest Of Latin America   
8.5.3 Middle East And Others   

9. Competitive Landscape   
9.1 Introduction   
9.2 Collaborations & Partnerships   
9.3 New Product Launches   
9.4 Agreements, Expantions & Mergers   
9.5 Company Matrix   

10. Major Companies   
10.1 Beckton Dickenson And Company   
10.1.1 Overview   
10.1.2 Financials   
10.1.3 Product Portfolio   
10.1.4 Key Developments   
10.1.5 Business Strategy   
10.1.6 SWOT Analysis   
10.2 Corning Incorporated   
10.2.1 Overview   
10.2.2 Financials   
10.2.3 Product Portfolio   
10.2.4 Key Developments   
10.2.5 Business Strategy   
10.2.6 SWOT Analysis   
10.3 Insphero Ag   
10.3.1 Overview   
10.3.2 Financials   
10.3.3 Product Portfolio   
10.3.4 Key Developments   
10.3.5 Business Strategy   
10.3.6 SWOT Analysis   
10.4 Jsr Corporation (Organogenix Inc.)   
10.4.1 Overview   
10.4.2 Financials   
10.4.3 Product Portfolio   
10.4.4 Key Developments   
10.4.5 Business Strategy   
10.4.6 SWOT Analysis   
10.5 Kuraray Co. Ltd   
10.5.1 Overview   
10.5.2 Financials   
10.5.3 Product Portfolio   
10.5.4 Key Developments   
10.5.5 Business Strategy   
10.5.6 SWOT Analysis   
10.6 Lonza Group   
10.6.1 Overview   
10.6.2 Financials   
10.6.3 Service Portfolio   
10.6.4 Key Developments   
10.6.5 Business Strategy   
10.6.6 SWOT Analysis   
10.7 Merck Kgaa   
10.7.1 Overview   
10.7.2 Financials   
10.7.3 Product Portfolio   
10.7.4 Key Developments   
10.7.5 Business Strategy   
10.7.6 SWOT Analysis   
10.8 Nano 3D Biosciences, Inc   
10.8.1 Overview   
10.8.2 Financials   
10.8.3 Product Portfolio   
10.8.4 Key Developments   
10.8.5 Business Strategy   
10.8.6 SWOT Analysis   
10.9 Organovo Holdings Inc.   
10.9.1 Overview   
10.9.2 Financials   
10.9.3 Product Portfolio   
10.9.4 Key Developments   
10.9.5 Business Strategy   
10.9.6 SWOT Analysis   
10.10 Thermo Fisher Scientific, Inc   
10.10.1 Overview   
10.10.2 Financials   
10.10.3 Product Portfolio   
10.10.4 Key Developments   
10.10.5 Business Strategy   
10.10.6 SWOT Analysis   

List Of Tables
Table 1 3D Cell Culture Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 2 3D Cell Culture Global Market Revenue, By Technology, (2016-2024) ($Mn)   
Table 3 Scaffold Based Platforms Global Market Revenue, By Type, (2016-2024) ($Mn)   
Table 4 Scaffold Based Platforms Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 5 Scaffolds Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 6 Hydrogels Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 7 Others Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 8 Scaffold Free Platforms Global Market Revenue, By Type, (2016-2024) ($Mn)   
Table 9 Scaffold Free Platforms Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 10 Hangdrop Method Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 11 Forced Floating Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 12 Agitation Based Methods Market Revenue,  By Regions, (2016-2024) ($Mn)   
Table 13 Microfluidics Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 14 3D Cell Culture Global Market Revenue, By Products, (2016-2024) ($Mn)   
Table 15 Cells & Tissues Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 16 Media, Sera & Reagents Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 17 Microplates & Others Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 18 Assay Kits Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 19 Scaffolds Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 20 Scaffolds Global Market Revenue, By Type, (2016-2024) ($Mn)   
Table 21 Natural Scaffolds Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 22 Synthetic Scaffolds Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 23 Hybrid Composite Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 24 Hydrogels Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 25 Others Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 26 3D Cell Culture Global Market Revenue, By Application, (2016-2024) ($Mn)   
Table 27 Basic Reasearch Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 28 Toxicity And Drug Safety Screening Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 29 Tissue Engineering Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 30 Stem Cell Research Market Revenue,  By Regions, (2016-2024) ($Mn)   
Table 31 Drug Discovery Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 32 Cancer Research Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 33 Gene Therapy Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 34 3D Cell Culture Global Market Revenue, By End-Users, (2016-2024) ($Mn)   
Table 35 Academic Institutes Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 36 Biotechnology And Pharmaceutical Industries Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 37 Others Market Revenue, By Regions, (2016-2024) ($Mn)   
Table 38 3D Cell Culture Global Market Revenue, By Region, (2016-2024) ($Mn)   
Table 39 North America 3D Cell Culture Market Revenue, By Technology (2016-2024) ($Mn)   
Table 40 North America Scaffold Based Platforms Market Revenue, By Type (2016-2024) ($Mn)   
Table 41 North America Scaffold Free Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 42 North America 3D Cell Culture Market Revenue, By Products, (2016-2024) ($Mn)   
Table 43 North America Scaffolds Market Revenue, By Type, (2016-2024) ($Mn)   
Table 44 North America 3D Cell Culture Market Revenue, By Application, (2016-2024) ($Mn)   
Table 45 North America 3D Cell Culture Market Revenue, By End-Users, (2016-2024) ($Mn)   
Table 46 Europe 3D Cell Culture Market Revenue,  By Technology (2016-2024) ($Mn)   
Table 47 Europe Scaffold Based Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 48 Europe Scaffold Free Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 49 Europe 3D Cell Culture Market Revenue, By Products, (2016-2024) ($Mn)   
Table 50 Europe Scaffolds Market Revenue, By Type, (2016-2024) ($Mn)   
Table 51 Europe 3D Cell Culture Market Revenue, By Application, (2016-2024) ($Mn)   
Table 52 Europe 3D Cell Culture Market Revenue, By End-Users, (2016-2024) ($Mn)   
Table 53 APAC 3D Cell Culture Market Revenue,  By Technology (2016-2024) ($Mn)   
Table 54 APAC Scaffold Based Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 55 APAC Scaffold Free Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 56 APAC 3D Cell Culture Market Revenue, By Products, (2016-2024) ($Mn)   
Table 57 APAC Scaffolds Market Revenue, By Type, (2016-2024) ($Mn)   
Table 58 APAC 3D Cell Culture Market Revenue, By Application, (2016-2024) ($Mn)   
Table 59 APAC 3D Cell Culture Market Revenue, By End-Users, (2016-2024) ($Mn)   
Table 60 Row 3D Cell Culture Market Revenue,  By Technology (2016-2024) ($Mn)   
Table 61 Row Scaffold Based Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 62 Row Scaffold Free Platforms Market Revenue,  By Type (2016-2024) ($Mn)   
Table 63 Row 3D Cell Culture Market Revenue, By Products, (2016-2024) ($Mn)   
Table64 Row Scaffolds Market Revenue, By Type, (2016-2024) ($Mn)   
Table65 Row 3D Cell Culture Market Revenue, By Application, (2016-2024) ($Mn)   
Table66 Row 3D Cell Culture Market Revenue, By End-Users, (2016-2024) ($Mn)   
Table67 Collaborations & Partnerships (Jan 2016 – Jan 2018)   
Table68 New Product Launch(Jan 2016 – Jan 2018)   
Table69 Agreements, Expantions & Mergers (Jan 2016 – Jan 2018)   
Table70 Company Matrix: Company V/S Product Offering   
Table71 Becton Dickinson And Company: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table72 Becton Dickinson And Company: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table73 Becton Dickinson And Company: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table74 Becton Dickinson And Company: Total Revenue, By Geography, (2015-2017) ($Mn)   
Table75 Corning Incorporated: Total Revenue And  R&D Expenses (2015-2017) ($Mn)   
Table76 Corning Incorporated: Total Revenue,  By Segment, (2015-2017) ($Mn)   
Table77 Corning Incorporated: Total Revenue,  By Geography (2012-2014) ($Mn)   
Table78 Kuraray Co. Ltd: Total Revenue And  R&D Expenses (2015-2017) ($Mn)   
Table79 Kuraray Co. Ltd. : Total Revenue,  By Segment, (2015-2017) ($Mn)   
Table80 Kuraray Co. Ltd: Total Revenue,  By Geography (2012-2014) ($Mn)   
Table81 Lonza Group: Total Revenue And  R&D Expenses (2015-2017) ($Mn)   
Table82 Lonza Group: Total Revenue, By Segment, (2015-2017) ($Mn)   
Table83 Lonza Group: Total Revenue,  By Geography (2015-2017) ($Mn)   
Table84 Merck Kgaa: Total Revenue And  R&D Expenses, (2015-2017) ($Mn)   
Table85 Merck Kgaa: Total Revenue, By Segments, (2015-2017) ($Mn)   
Table86 Merck Kgaa: Total Revenue, By Geography, (2015-2017) ($Mn)   
Table87 Organovo Holdings Inc.: Total Revenue And  R&D Expenses (2015-2017) ($Mn)   
Table 88 Thermo Fisher Scientific, Inc: Total Revenue And  R&D Expenses (2015-2017) ($Mn)   
Table 89 Thermo Fisher Scientific, Inc : Total Revenue,  By Segment, (2015-2017) ($Mn)   
Table 90 Thermo Fisher Scientific, Inc: Total Revenue,  By Geography (2015-2017) ($Mn)   

List Of Figures
Figure1 Global 3D Cell Culture Market Share And Revenue, By Region, (2016-2024) ($Mn)   
Figure2 Research Methodology: 3D Cell Culture Global Market   
Figure33 D Cell Culture Global Market:  Top-Down And Bottom-Up Approach   
Figure43 D Cell Culture Global Market:  Forecasting Model   
Figure53 D Cell Culture: Market Breakdown & Data Triangulation   
Figure63 D Cell Culture Global Market: Market Segmentation   
Figure83 D Cell Culture Market: Porter’S Analysis   
Figure93 D Cell Culture Global Market: Supply Chain Analysis   
Figure103 D Cell Culture Global Market Share Analysis,  By Key Players, 2017       
Figure113 D Cell Culture Global Market Revenue, By Technology, (2017-2024) ($Mn)   
Figure 12 3D Cell Culture Scaffold Based Platforms Global Market Revenue, By Type,  (2017) ($Mn)   
Figure 13 3D Cell Culture Scaffold Free Platforms Global Market Revenue, By Type,  (2017) ($Mn)   
Figure 14Scaffold Based Platforms Global Market Revenue, By Type, (2016-2024) ($Mn)   
Figure 15 Scaffold Free Platforms Global Market Revenue, By Type, (2016-2024) ($Mn)   
Figure 16 3D Cell Culture Global Market Revenue, By Product, (2017 V/S 2024) ($Mn)   
Figure 17 Scaffolds Global Market Revenue, By Type,  (2017 V/S 2024) ($Mn)   
Figure 18 3D Cell Culture Global Market Revenue, By Application, (2017 V/S 2024) ($Mn)   
Figure 19 3D Cell Culture Global Market Share, By Application, (2017) (%) Cagr (%)   
Figure 20 3D Cell Culture Global Market Revenue, By End-Users, (2017 V/S 2024) ($Mn)   
Figure 21 3D Cell Culture Global Market Revenue,  By Region (2016-2024) ($Mn)   
Figure 22 North America 3D Cell Culture Market Revenue,  By Technology (2017 Vs 2024) ($Mn)   
Figure 23 North America Scaffold Based Platforms & Scaffold Free Platform Market, By Type (2017 Vs 2024) ($Mn)   
Figure 24 North America 3D Cell Culture Market Revenue,  By Products (2017 Vs 2024) ($Mn)   
Figure 25 North America Scaffolds Market Revenue,  By Type (2017 Vs 2024) ($Mn)   
Figure 26 North America 3D Cell Culture Market Revenue,  By Application (2017 Vs 2024) ($Mn)   
Figure 27 North America 3D Cell Culture Market Revenue,  By End-Users (2017 Vs 2024) ($Mn)   
Figure 28 U.S. 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 29 U.S. 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 30 Other North American Countries 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 31 Other North American Countries 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 32 Europe 3D Cell Culture Market Revenue,  By Technology (2017 Vs 2024) ($Mn)   
Figure 33 Europe Scaffold Based Platforms & Scaffold Free Platform Market, By Type (2017 Vs 2024) ($Mn)   
Figure 34 Europe 3D Cell Culture Market Revenue,  By Products (2017 Vs 2024) ($Mn)   
Figure 35 Europe Scaffolds Market Revenue,  By Type (2017 Vs 2024) ($Mn)   
Figure 36 Europe 3D Cell Culture Market Revenue,  By Application (2017 Vs 2024) ($Mn)   
Figure 37 Europe 3D Cell Culture Market Revenue,  By End-Users (2017 Vs 2024) ($Mn)   
Figure 38 Germany 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products  (2017 Vs 2024) ($Mn)   
Figure 39 Germany 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 40 U.K. 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products  (2017 Vs 2024) ($Mn)   
Figure 41 U.K. 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 42 France 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products  (2017 Vs 2024) ($Mn)   
Figure 43 France 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 44 Other European Countries 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products  (2017 Vs 2024) ($Mn)   
Figure 45 Other European Countries 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 46 APAC 3D Cell Culture Market Revenue,  By Technology (2017 Vs 2024) ($Mn)   
Figure 47 APAC Scaffold Based Platforms & Scaffold Free Platform Market, By Type (2017 Vs 2024) ($Mn)   
Figure 48 APAC 3D Cell Culture Market Revenue,  By Products (2017 Vs 2024) ($Mn)   
Figure 49 APAC Scaffolds Market Revenue,  By Type (2017 Vs 2024) ($Mn)   
Figure 50 APAC 3D Cell Culture Market Revenue,  By Application (2017 Vs 2024) ($Mn)   
Figure 51 APAC 3D Cell Culture Market Revenue,  By End-Users (2017 Vs 2024) ($Mn)   
Figure 52 China 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 53 China 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 54 Japan 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 55 Japan 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 56 Korea 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 57 Korea 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 58 Other APAC Countries 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 59 Other APAC Countries 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure 60 Row 3D Cell Culture Market Revenue,  By Technology (2017 Vs 2024) ($Mn)   
Figure 61 Row Scaffold Based Platforms & Scaffold Free Platform Market, By Type (2017 Vs 2024) ($Mn)   
Figure 62 Row 3D Cell Culture Market Revenue,  By Products (2017 Vs 2024) ($Mn)   
Figure 63 Row Scaffolds Market Revenue,  By Type (2017 Vs 2024) ($Mn)   
Figure 64 Row 3D Cell Culture Market Revenue,  By Application (2017 Vs 2024) ($Mn)   
Figure 65 Row 3D Cell Culture Market Revenue,  By End-Users (2017 Vs 2024) ($Mn)   
Figure 66 Brazil 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure 67 Brazil 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure68 Rest Of Latin America 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure69 Rest Of Latin America 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure70 Middle East And Others 3D Cell Culture Market Revenue,  By Technology, By End-Users & By Products (2017 Vs 2024) ($Mn)   
Figure71 Middle East And Others 3D Cell Culture Market Revenue,  By Applications (2017 Vs 2024) ($Mn)   
Figure72 Key Growth Strategies, (Jan 2016 – Jan 2018)   
Figure73 Overview: Becton Dickinson And Company   
Figure74 SWOT: Becton Dickinson And Company   
Figure75 Overview: Corning Incorporated   
Figure76 SWOT: Corning Incorporated   
Figure77 SWOT: Insphero Ag   
Figure78 SWOT: Organogenix Inc.   
Figure79 Overview: Kuraray Co. Ltd   
Figure80 SWOT: Kuraray Co. Ltd   
Figure81 Overview: Lonza Group   
Figure82 SWOT: Lonza Group   
Figure83 Overview: Merck Kgaa   
Figure84 SWOT: Merck Kgaa   
Figure85 SWOT: Nano 3D Biosciences   
Figure86 Overview: Organovo Holdings Inc.   
Figure87 SWOT: Organovo Holdings Inc   
Figure88 Overview: Thermo Fisher Scientific Inc   
Figure89 SWOT: Thermo Fisher Scientific, Inc

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3D Matrix Co (Japan)
  • Ascendance (U.S.)
  • Biolamina AB (Sweden)
  • Corning (U.S.)
  • Fujifilm (Japan)
  • Insphero (Switzerland)
  • MORE

The first  attempt  to culture cell  artificially  dates back  to  1907,  where Dr. Ross Harrison,  an Anatomy Professor, developed hanging drop technique to grow three-dimensional (3D) frog embryonic  nerve  fragments  via  a  coverslip.  Since  then,  life  science  researchers  have depended on primarily adherent, two-dimensional (2D) cell culture techniques where cells of interest  are  cultured  in  plastic  or  glassware  for  study  of  human  cells,  tissues,  and  disease models.

As intricacies of these techniques are understood advanced 3D models have been developed  which  greatly  influence  the  in-vitro  culturing  and  driving  cell  culture  market.

In contrast  to  2D  environment,  cells  grown  in  three-dimensions  display  higher  degree  of intercellular  interactions,  assume  more  physiologically  relevant  morphologies  and  preserve higher-order  tissue  processes.  Tools,  technologies,  and  protocols  are  making  in-vitro  3D analysis  simple,  cheap,  reproducible  and  scalable-enough  for  adaptation  in  drug development. 

As  these  tools  have  become  more  accessible  and  validated,  researchers  in both  academia  and  biopharma  are  shifting  their  attention  from  2D  to  3D  cell  culture.  As estimated  by this research,  the  3D  cell  culture  global  market  is  valued  at  $XX  million  in 2017 and is expected to grow at a low double digit CAGR to reach $1,485.1 million by 2024.

Rising investments in research and development, increasing need for organ transplantation, use of 3D cell culture models as a tool against animal testing, use of microfluidic technology, and increasing focus  on  regenerative medicine  are  some  of the factors that  are driving  the market  growth.

The  entry  of  new  players  with  novel  technologies  and  introduction  of technology driven products are creating an opportunity in the global 3D cell culture market. Whereas, Lack of experienced and skilled research professionals, lack of consistency in 3D cell  culture  products  and  budget  restriction  for  small  and  medium-sized  laboratories  are hindering the market growth.

Stringent regulatory process controls and ethical concern over animal source usage are the major threat to the market. 

The recent progress in microfluidic technology, scaffolds, spheroids and gels-based systems is making lot of difference in the market as they provide micro-scale complex structures and well-controlled  parameters  to  mimic  the in  vivo environment  of  cells  and  thereby  gives  an opportunity for scientists to explore new applications such as tissue engineering, stem cell, drug  discovery  and  regenerative  medicine.

The  rapid  advancements  in  the  field  of  cell culture such as 3D bioprinting, organ-on-chip, and single use bioreactors is advancing day- by-day and has been accepted as the future direction of 3D cell culture market. Now-a-days, ultra  low  attachment  micro-plates  (ULA)  applications  are  increasing  as  researchers  are focusing on single spheroid and microtissue production for downstream assay compatibility driving  demand  for  ultra  low  attachment  microplates. For  instance,  InSphero  AG (Switzerand),  Corning  Incorporated  (U.S.),  Perkin  Elmer  (U.S)  are  some  the  major companies manufacturing these plates.

The  3D  cell  culture  technology  global  market  is  broadly  classified  into  scaffold  based platforms and scaffold free platforms, of which the scaffold based platforms, hold the largest share  in  2017.  However  the  scaffold  free  platforms  are  expected  to  grow  at  a  faster  rate.

Furthermore  scaffolds  hold  the  largest  share  among  the  scaffold  based  platforms  that include hydrogels and other products as well. Similarly, the forced floating method occupied the largest share within the scaffold free market when compared to the other methods such as hanging drop method, agitation based methods and microfluidics.

A number of product categories are available in the 3D cell culture market that include cells & tissues, media, sera and reagents, microplates and others, assay kits, scaffolds and other products.  The  media,  sera  and  reagents  segment  occupy  the  largest  share  in  2017. However the scaffolds market seems to be the fastest growing, due to the advancements in technologies in this area including the uptake of bioprinting technology.

There are  a number  of applications in which 3D  cell  culture  products  are used that  include basic  research,  toxicity  and  drug  safety  screening,  tissue  engineering,  stem  cell  research, drug discovery, gene therapy and cancer research. The toxicity and drug safety screening is a field in which recent advanced are recognized making it the largest segment in 2017.

From an end-users  perspective  the  biotechnology  and  pharmaceutical  industries  occupy  the largest share in 2017 followed by CROs and hospitals is growing at the fast rate.

Geographically,  3D  cell  culture  market  is  divided  into  North  America,  Europe,  Asia-Pacific and Rest of the world. North America dominated the market with largest share in 2017, due to increased government funding, rising incidence of cancer, development of new models for candidate  drug  screening  and  cytotoxicity  testing,  expanding  biopharmaceutical  industries and  high  healthcare  expenditure. 

Europe  accounts  for  second  largest  share  followed  by Asia-pacific region and it is expected to grow at the highest rate due to increased healthcare awareness,  improved  economic  growth,  low  operating  cost  and  increased  outsourcing. Significant new product launches, collaborations and partnerships joint ventures are some of the industry trends that are playing a major role for the market growth.

Note: Product cover images may vary from those shown
5 of 5
  • 3D Matrix Co (Japan)
  • AMSBio LLC (U.S.)
  • Ascendance (U.S.)
  • Becton Dickenson & Company (U.S.)
  • BioCellChallenge (France)
  • Biolamina AB (Sweden)
  • CellecBiotek AG (Switzerland)
  • CelVivo IVS (Denmark)
  • Corning (U.S.)
  • Cytoo (France)
  • Fujifilm (Japan)
  • Hurel Corp (U.S.)
  • Insphero (Switzerland)
  • JSR Corporation (Organogenix  Inc.)(Japan)
  • Kuraray Co. Ltd. (Japan)
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Nano 3D Biosciences  (U.S.)
  • Nanopahrma AS (Czech Republic)
  • Organovo Holdings Inc. (U.S.).
  • Prodizen (Korea)
  • Thermofisher  Scientific (U.S.)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll